選択的セロトニン再取り込み阻害薬および5-HT2A受容体拮抗薬を含有する組成物

Title:

選択的セロトニン再取り込み阻害薬および5-HT2A受容体拮抗薬を含有する組成物

Document Type and Number:

Japanese Patent JP2007516204

Kind Code:

A

Abstract:

Novel compositions comprising a selective serotonin re-uptake inhibitor (SSRI), particularly sertraline, and a selective inhibitor for the binding of serotonin at the 5HT2A site. The invention relates to the use of such compositions for treating or preventing mood disorders including depression and anxiety disorders.

More Like This:

WO/2021/258016	COMBINING IPSC-DERIVED EFFECTOR CELL TYPES FOR IMMUNOTHERAPY USE
WO/2022/247846	COMBINATION OF DOCETAXEL ALBUMIN COMPOSITION AND IMMUNE CHECKPOINT INHIBITOR AND USE THEREOF
WO/2020/068163	METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT

Inventors:

Robert Mark Berman
Gerrard Joseph Marek

Application Number:

JP2006518386A

Publication Date:

June 21, 2007

Filing Date:

June 21, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Pfizer Products Inc.

International Classes:

A61K45/06; A61K31/135; A61K31/137; A61K31/138; A61K31/15; A61K31/255; A61K31/343; A61K31/445; A61K31/4525; A61K31/7034; A61P25/00; A61P25/14; A61P25/22; A61P25/24; A61P25/28; A61P43/00

Attorney, Agent or Firm:

Yoshinobu Murofushi

Previous Patent: 炎症の治療に有用なインドール類

Next Patent: インドール、アザインドール、および関連するヘテロ環状Ｎ−置換ピペラ�...